This article was originally published in The Gray Sheet
Maxxim completes cash tender offer for 12.5 mil. Circon shares (93%) at $15 per share on Jan. 5. Under the terms of the acquisition deal, originally announced Nov. 21 and valued at $243 mil. ("The Gray Sheet" Nov. 30, p. 21), holders of Circon shares not tendered also will be entitled to $15 per share. With net sales of $522 mil. for fiscal year 1998 (ended Nov. 1), 1.3% less than the previous year, Maxxim predicts that the addition of Circon will "significantly boost revenues" for fiscal 1999. Maxxim also reports a 52.4% gain in net income to $19.6 mil
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.